Identification of apposite antagonist for androgen receptor in prostate cancer: an in silico study of fenugreek compounds.
Fenugreek compounds were tested for their potential as anti-cancer agents on benign prostate cancer by targeting the androgen receptor. The compounds chlorogenic acid and kaempferol showed the most promise, indicating their potential for drug development in BPC treatment. (25 words)
- Olugbogi EA et al (2023).
- J Biomol Struct Dyn.
- PubMed:
- 37897191